Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 4 3Phase 2 3Phase 2/3 2

Status

Completed 28Unknown 3Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Lung Metastases 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Metformin 16Cyclophosphamide 15Drug Therapy 14Dexamethasone 14Cisplatin 14Cytarabine 11Gemcitabine 10Radiotherapy 9Carboplatin 9Vincristine 8Paclitaxel 8Oxaliplatin 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Zoledronic Acid × Clear all
NCT03932071 2019-05-06

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Unknown
150 enrolled

Lung Metastases

NCT02480634 2019-01-16

Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 4 Unknown
280 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00912938 2010-02-17

Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients

Korean Breast Cancer Study Group

Phase 4 Unknown
237 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡